Related Experiment Video

Updated: Aug 21, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Pediatric considerations

Margaret M Parker1, Jan A Hazelzet, Joseph A Carcillo

  • 1Department of Pediatrics, Stony Brook University, Stony Brook, NY, USA.

Critical Care Medicine
|November 16, 2004
PubMed

Insights

Critical care experts developed sepsis management guidelines for bedside clinicians. Pediatric considerations highlight unique needs in intubation, fluid resuscitation, and hemodynamic profiles for severe sepsis.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pediatric Critical Care

Background:

  • Sepsis management guidelines are crucial for improving outcomes in severe sepsis.
  • The Surviving Sepsis Campaign aims to increase awareness and enhance patient care.
  • International collaboration is key to developing practical, evidence-based guidelines.

Purpose of the Study:

  • To develop practical management guidelines for supportive therapies in sepsis for bedside clinicians.
  • To address the specific needs and challenges of pediatric sepsis management.
  • To provide a consensus-based approach to sepsis care.

Main Methods:

  • Modified Delphi method and consensus conference.
  • Subgroup meetings, teleconferences, and electronic discussions.
  • Inclusion of pediatric representatives to highlight pediatric-specific considerations.

Main Results:

  • Guidelines developed by experts from 11 international organizations.
  • Pediatric considerations identified unique management needs.
  • Specific pediatric challenges include intubation, IV access, and fluid resuscitation.

Conclusions:

  • Pediatric sepsis management requires tailored approaches.
  • Key pediatric considerations include respiratory support, fluid volume, and hemodynamic monitoring.
  • Further research is needed on specific interventions like high-dose steroids and glucose control in pediatric septic shock.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...